Artificial intelligence (AI) is revolutionizing the pharmaceutical industry by expediting the discovery of new drugs, particularly for challenging diseases. Traditionally, drug development has been a time-consuming and costly endeavor, often taking over a decade and billions of dollars to bring a new medication to market. AI-driven approaches are now streamlining this process by identifying potential drug candidates more efficiently.